Hendrickson N M, Amerson A B
Am J Hosp Pharm. 1986 Oct;43(10):2468-73.
Drug reviews appearing in Clinical Pharmacy, Drug Intelligence and Clinical Pharmacy (DICP), Drugs, and Pharmacotherapy from January 1982 through December 1984 were evaluated for number, duplication among journals, timeliness, scope, and format. The design of this study was primarily quantitative rather than qualitative. Pharmacotherapy published the most reviews (49), followed by Drugs (43), Clinical Pharmacy (37), and DICP (29). Drugs and Pharmacotherapy published the largest number of unique reviews (agents not reviewed by the other journals during the study period), while Pharmacotherapy and Clinical Pharmacy published the most reviews on newly marketed drugs. Reviews of four drugs (acyclovir, moxalactam, ranitidine, and trazodone) were compared in terms of major sections, terminology and format, bibliography, use of tables and figures, scope of evaluative comments, and review process. Reviews in Drugs consistently contained the most references and tables and provided the most detail. Information was most accessible in Drugs, followed by Pharmacotherapy. Drugs used the largest panel of reviewers. All of the journals provided evaluative comments, although the scope varied. Continuing-education credit is available for review articles in Clinical Pharmacy and DICP. In selecting one or more of these journals, individuals or institutions should compare their needs with regard to the timeliness, scope, and format of the review articles in each journal.
对1982年1月至1984年12月发表于《临床药学》《药物情报与临床药学》（DICP）、《药物》及《药物治疗学》上的药物综述，从数量、期刊间重复情况、时效性、范围及格式等方面进行了评估。本研究设计主要是定量而非定性的。《药物治疗学》发表的综述最多（49篇），其次是《药物》（43篇）、《临床药学》（37篇）和《药物情报与临床药学》（DICP，29篇）。《药物》和《药物治疗学》发表的独特综述数量最多（研究期间其他期刊未综述的药物），而《药物治疗学》和《临床药学》发表的关于新上市药物的综述最多。对四种药物（阿昔洛韦、拉氧头孢、雷尼替丁和曲唑酮）的综述在主要章节、术语与格式、参考文献、图表使用、评价性评论范围及综述过程等方面进行了比较。《药物》上的综述一直包含最多的参考文献和表格，且提供的细节最多。信息在《药物》上最易获取，其次是《药物治疗学》。《药物》使用的审稿人小组规模最大。所有期刊均提供评价性评论，尽管范围有所不同。《临床药学》和《药物情报与临床药学》上的综述文章可获得继续教育学分。在选择这些期刊中的一种或多种时，个人或机构应将自身需求与每种期刊综述文章的时效性、范围及格式进行比较。
